Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct

Background and Purpose— Magnetic resonance imaging (MRI) selection of stroke patients eligible for thrombolytic therapy is an emerging application. Although the efficacy of therapy within 3 hours after onset of symptoms with intravenous (IV) tissue plasminogen activator (tPA) has been proven for patients selected with computed tomography (CT), no randomized, double-blinded MRI trial has been published yet. Summary of Review— MRI screening of acute stroke patients before thrombolytic therapy is performed in some cerebrovascular centers. In contrast to the CT trials, MRI pilot studies demonstrate benefit of therapy up to 6 hours after onset of symptoms. This article reviews the literature that has lead to current controlled MRI-based thrombolysis trials. We examined the MRI criteria applied in 5 stroke centers. Along with the personal views of clinicians at these centers, the survey reveals a variety of clinical and MRI technical aspects that must be further investigated: the therapeutic consequence of microbleeds, the use of magnetic resonance angiography, dynamic time windows, and others. Conclusion— MRI is an established application in acute evaluation of stroke patients and may suit as a brain clock, replacing the currently used epidemiological time clock when deciding whether to initiate thrombolytic therapy. MRI criteria for thrombolytic therapy are applied in some cerebrovascular centers, but the results of ongoing clinical trials must be awaited before it is possible to reach consensus.

[1]  D. Bihan.  Diffusion and Perfusion in MRI , 2007 .

[2]  Scott Hamilton,et al.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.

[3]  A. Villringer,et al.  Stroke Magnetic Resonance Imaging Is Accurate in Hyperacute Intracerebral Hemorrhage: A Multicenter Study on the Validity of Stroke Imaging , 2004, Stroke.

[4]  C. Weiller,et al.  Predictors of Apparent Diffusion Coefficient Normalization in Stroke Patients , 2004, Stroke.

[5]  Y. H. Kim,et al.  Cerebral microbleeds are regionally associated with intracerebral hemorrhage , 2004, Neurology.

[6]  Steven Warach,et al.  Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era , 2004, Annals of neurology.

[7]  G. Donnan,et al.  The frequency of perfusion-diffusion mismatch decreases with objective definition , 2004 .

[8]  Jérôme Honnorat,et al.  Thrombolysis for Ischemic Stroke in Patients with Old Microbleeds on Pretreatment MRI , 2003, Cerebrovascular Diseases.

[9]  J. Alger,et al.  Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging , 2003, Stroke.

[10]  Leif Østergaard,et al.  Effects of tracer arrival time on flow estimates in MR perfusion‐weighted imaging , 2003, Magnetic resonance in medicine.

[11]  E. Kanal,et al.  The Cortical Ischemic Core and Not the Consistently Present Penumbra Is a Determinant of Clinical Outcome in Acute Middle Cerebral Artery Occlusion , 2003, Stroke.

[12]  G. Donnan,et al.  Perfusion thresholds in acute stroke thrombolysis. , 2003, Stroke.

[13]  B. Rosen,et al.  Tracer arrival timing‐insensitive technique for estimating flow in MR perfusion‐weighted imaging using singular value decomposition with a block‐circulant deconvolution matrix , 2003, Magnetic resonance in medicine.

[14]  Richard Frayne,et al.  Reliability of Assessing Percentage of Diffusion-Perfusion Mismatch , 2003, Stroke.

[15]  Jeffry R Alger,et al.  Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue , 2003, Stroke.

[16]  P. Adeleine,et al.  Baseline Magnetic Resonance Imaging Parameters and Stroke Outcome in Patients Treated by Intravenous Tissue Plasminogen Activator , 2003, Stroke.

[17]  Jeffry R Alger,et al.  Late secondary ischemic injury in patients receiving intraarterial thrombolysis , 2002, Annals of neurology.

[18]  R. Knab,et al.  Cerebral Blood Flow Predicts Lesion Growth in Acute Stroke Patients , 2002, Stroke.

[19]  A. Villringer,et al.  Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours , 2002, Stroke.

[20]  J. Thiran,et al.  Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients , 2002, Stroke.

[21]  Jean-Philippe Thiran,et al.  Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients , 2002, Annals of neurology.

[22]  J C Froment,et al.  Old Microbleeds Are a Potential Risk Factor for Cerebral Bleeding After Ischemic Stroke: A Gradient-Echo T2*-Weighted Brain MRI Study , 2002, Stroke.

[23]  Stephen Rose,et al.  Diffusion‐ and perfusion‐weighted MRI response to thrombolysis in stroke , 2002, Annals of neurology.

[24]  Masafumi Harada,et al.  Can Diffusion- and Perfusion-weighted Magnetic Resonance Imaging Evaluate the Efficacy of Acute Thrombolysis in Patients with Internal Carotid Artery or Middle Cerebral Artery Occlusion? , 2002, Neurosurgery.

[25]  Fernando Vinuela,et al.  Magnetic Resonance Imaging Detection of Microbleeds Before Thrombolysis: An Emerging Application , 2002, Stroke.

[26]  Leif Østergaard,et al.  Magnetic Resonance Perfusion-Weighted Imaging of Acute Cerebral Infarction: Effect of the Calculation Methods and Underlying Vasculopathy , 2002, Stroke.

[27]  C. Weiller,et al.  Severe ADC Decreases Do Not Predict Irreversible Tissue Damage In Humans , 2002, Stroke.

[28]  D Le Bihan,et al.  Prediction of tissue survival after middle cerebral artery occlusion based on changes in the apparent diffusion of water. , 2001, Journal of neurosurgery.

[29]  Christopher Putman,et al.  Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated With Intra-Arterial Thrombolysis:: Prediction of Final Infarct Volume and Clinical Outcome , 2001, Stroke.

[30]  F. Buonanno,et al.  Predicting Tissue Outcome in Acute Human Cerebral Ischemia Using Combined Diffusion- and Perfusion-Weighted MR Imaging , 2001, Stroke.

[31]  R J Seitz,et al.  Diffusion- and perfusion-weighted MRI: influence of severe carotid artery stenosis on the DWI/PWI mismatch in acute stroke. , 2000, Stroke.

[32]  W. Hacke,et al.  Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. , 2000, Stroke.

[33]  Gary Duckwiler,et al.  Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging , 2000, Annals of neurology.

[34]  G. Albers,et al.  Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. , 1999, JAMA.

[35]  J S Lewin,et al.  Hyperacute stroke: ultrafast MR imaging to triage patients prior to therapy. , 1999, Radiology.

[36]  R J Seitz,et al.  Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. , 1999, Stroke.

[37]  David L. Thomas,et al.  Measuring Cerebral Blood Flow Using Magnetic Resonance Imaging Techniques , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  W. Hacke,et al.  Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI , 1999, The Lancet.

[39]  M E Moseley,et al.  Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI , 1999, Neurology.

[40]  W. Hacke,et al.  CT angiography and Doppler sonography for emergency assessment in acute basilar artery ischemia. , 1999, Stroke.

[41]  B R Rosen,et al.  Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. , 1999, Radiology.

[42]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[43]  S M Davis,et al.  Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI , 1998, Neurology.

[44]  E. Barmeir,et al.  Duplex scanning and CT angiography in the diagnosis of carotid artery occlusion: a prospective study. , 1998, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[45]  S. Warach,et al.  Magnetic Resonance Imaging of Acute Stroke , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  W. Hacke,et al.  Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke. , 1998, Stroke.

[47]  T. Benner,et al.  Perfusion‐weighted MRI using gadobutrol as a contrast agent in a rat stroke model , 1997, Journal of magnetic resonance imaging : JMRI.

[48]  R R Edelman,et al.  Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke , 1997, Neurology.

[49]  K. Sartor,et al.  Potential of CT angiography in acute ischemic stroke. , 1997, AJNR. American journal of neuroradiology.

[50]  D. Shibata,et al.  CT angiography in the evaluation of acute stroke. , 1997, AJNR. American journal of neuroradiology.

[51]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results , 1996, Magnetic resonance in medicine.

[52]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.

[53]  R R Edelman,et al.  Clinical Outcome in Ischemic Stroke Predicted by Early Diffusion-Weighted and Perfusion Magnetic Resonance Imaging: A Preliminary Analysis , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[54]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[55]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[56]  Seong-Gi Kim.  Quantification of relative cerebral blood flow change by flow‐sensitive alternating inversion recovery (FAIR) technique: Application to functional mapping , 1995, Magnetic resonance in medicine.

[57]  W. Hacke,et al.  Does arterial recanalization improve outcome in carotid territory stroke? , 1995, Stroke.

[58]  B. Siewert,et al.  Acute human stroke studied by whole brain echo planar diffusion‐weighted magnetic resonance imaging , 1995, Annals of neurology.

[59]  B. Dardzinski,et al.  MRI diffusion mapping of reversible and irreversible ischemic injury in focal brain ischemia , 1994, Neurology.

[60]  N Fujita,et al.  MR imaging of middle cerebral artery stenosis and occlusion: value of MR angiography. , 1994, AJNR. American journal of neuroradiology.

[61]  M. Kaste,et al.  The European Cooperative Acute Stroke Study (ECASS) , 1993 .

[62]  V M Runge,et al.  Contrast‐enhanced MR angiography , 1993, Journal of magnetic resonance imaging : JMRI.

[63]  N M Branston,et al.  Cortical Evoked Potential and Extracellular K+ and H+ at Critical Levels of Brain Ischemia , 1977, Stroke.